MTF Practice Grant supports researchers studying the clinical and economic benefits of direct medical toxicology care to demonstrate its value and advance prevention and treatment of toxic harm.
Funder: Medical Toxicology Foundation
Due Dates: March 1, 2027 (Application) | January 11, 2027 (Information session)
Funding Amounts: Up to $10,000 per award; up to 2 awards for July 1, 2027–June 30, 2028
Summary: Supports research measuring the clinical and/or economic benefits of medical toxicology services in inpatient, outpatient, and telemedicine settings.
Key Information: Either the principal or senior investigator must be an active ACMT member in good standing.
The Medical Toxicology Foundation (MTF), the philanthropic arm of the American College of Medical Toxicology (ACMT), supports research evaluating the value of medical toxicology services. The program aims to help demonstrate these services’ benefits to leaders in hospitals, healthcare systems, nonprofit organizations, and governments, while advancing the prevention and treatment of harm from drugs, chemicals, and natural toxins.
Projects should measure the impact of direct medical toxicology care using clinical and/or economic outcomes. Relevant services include bedside consultation, outpatient care, and telemedicine for poisonings, overdoses, adverse drug reactions, envenomations, withdrawal syndromes, and substance use disorders. Potential measures include patient outcomes, costs and savings, care processes, treatment utilization, and safety. Evaluation of interventions or services conducted by a Poison Center is outside the award’s scope.